The 2nd Non-Invasive Brain Neuromodulation Meeting – NIBS Chile 2026 will bring together healthcare professionals and researchers on January 16 and 17 in Temuco, for a scientific update and clinical...
Read more...
Recent evidence shows that the timing of stimulation—before, during, or after—depends on the type of task: cognitive, motor, or psychotherapeutic. An analysis conducted by Dr. Lucía del Valle, a PhD...
Read more...
CandelStim tDCS is a medical device for prescription use in Chile and must always be used under the supervision of a healthcare professional, following the instructions of the treating physician. Like any medical treatment, it is not entirely risk-free, and its results may vary among patients. Before use, the applicable product information must be reviewed, and the treating professional consulted.